Skip to main content
Log in

Tick-borne encephalitis vaccine cost effective in Sweden

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2017 Swedish krona

Reference

  • Shedrawy J, et al. Estimating costs and health outcomes of publicly funded tick-born encephalitis vaccination: A cost-effectiveness analysis. Vaccine : 30 Oct 2018. Available from: URL: http://doi.org/10.1016/j.vaccine.2018.10.086

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tick-borne encephalitis vaccine cost effective in Sweden. PharmacoEcon Outcomes News 816, 31 (2018). https://doi.org/10.1007/s40274-018-5451-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5451-8

Navigation